» Articles » PMID: 29682284

Staphylococcal Enterotoxin C2 Promotes Osteogenesis of Mesenchymal Stem Cells and Accelerates Fracture Healing

Overview
Journal Bone Joint Res
Date 2018 Apr 24
PMID 29682284
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: As one of the heat-stable enterotoxins, C2 (SEC2) is synthesized by , which has been proved to inhibit the growth of tumour cells, and is used as an antitumour agent in cancer immunotherapy. Although SEC2 has been reported to promote osteogenic differentiation of human mesenchymal stem cells (MSCs), the function of SCE2 in animal model remains elusive. The aim of this study was to further elucidate the effect of SCE2 on fracture healing.

Materials And Methods: Rat MSCs were used to test the effects of SEC2 on their proliferation and osteogenic differentiation potentials. A rat femoral fracture model was used to examine the effect of local administration of SEC2 on fracture healing using radiographic analyses, micro-CT analyses, biomechanical testing, and histological analyses.

Results: While SEC2 was found to have no effect on rat MSCs proliferation, it promoted the osteoblast differentiation of rat MSCs. In the rat femoral fracture model, the local administration of SEC2 accelerated fracture healing by increasing fracture callus volumes, bone volume over total volume (BV/TV), and biomechanical recovery. The SEC2 treatment group has superior histological appearance compared with the control group.

Conclusion: These data suggest that local administration of SEC2 may be a novel therapeutic approach to enhancing bone repair such as fracture healing.: T. Wu, J. Zhang, B. Wang, Y. Sun, Y. Liu, G. Li. Staphylococcal enterotoxin C2 promotes osteogenesis of mesenchymal stem cells and accelerates fracture healing. 2018;7:179-186. DOI: 10.1302/2046-3758.72.BJR-2017-0229.R1.

Citing Articles

T cell related osteoimmunology in fracture healing: Potential targets for augmenting bone regeneration.

Wang H, Li Y, Li H, Yan X, Jiang Z, Feng L J Orthop Translat. 2025; 51:82-93.

PMID: 39991456 PMC: 11847249. DOI: 10.1016/j.jot.2024.12.004.


Loss in Pluripotency Markers in Mesenchymal Stem Cells upon Infection with .

Al-Zeer M, Abu Lubad M J Microbiol Biotechnol. 2024; 34(12):2465-2473.

PMID: 39467689 PMC: 11733544. DOI: 10.4014/jmb.2406.06023.


Effects of Staphylococcus aureus on stem cells and potential targeted treatment of inflammatory disorders.

Liu Z, Liu G, Lin Z, Chen Y, Chen P, Hu Y Stem Cell Res Ther. 2024; 15(1):187.

PMID: 38937829 PMC: 11210046. DOI: 10.1186/s13287-024-03781-6.


Low-Dose Staphylococcal Enterotoxin C2 Mutant Maintains Bone Homeostasis via Regulating Crosstalk between Bone Formation and Host T-Cell Effector Immunity.

Wang H, Lin S, Feng L, Huang B, Lu X, Yang Z Adv Sci (Weinh). 2023; 10(28):e2300989.

PMID: 37552005 PMC: 10558680. DOI: 10.1002/advs.202300989.


The reconstruction of critical bone loss : the holy grail of orthopaedics.

Tsang S, Ferreira N, Simpson A Bone Joint Res. 2022; 11(6):409-412.

PMID: 35731230 PMC: 9233404. DOI: 10.1302/2046-3758.116.BJR-2022-0186.


References
1.
Wang X, Xu M, Zhang H, Liu J, Li X, Zhang C . Enhancement of superantigen activity and antitumor response of staphylococcal enterotoxin C2 by site-directed mutagenesis. Cancer Immunol Immunother. 2008; 58(5):677-86. PMC: 11030829. DOI: 10.1007/s00262-008-0590-6. View

2.
Liu Y, Xu M, Zhang H, Li X, Su Z, Zhang C . SEC2-induced superantigen and antitumor activity is regulated through calcineurin. Appl Microbiol Biotechnol. 2013; 97(22):9695-703. DOI: 10.1007/s00253-013-4764-6. View

3.
Nakase T, Takaoka K, Hirakawa K, Hirota S, Takemura T, Onoue H . Alterations in the expression of osteonectin, osteopontin and osteocalcin mRNAs during the development of skeletal tissues in vivo. Bone Miner. 1994; 26(2):109-22. DOI: 10.1016/s0169-6009(08)80056-6. View

4.
Siller A, Whyte M . Alkaline Phosphatase: Discovery and Naming of Our Favorite Enzyme. J Bone Miner Res. 2017; 33(2):362-364. DOI: 10.1002/jbmr.3225. View

5.
Mifuji K, Ishikawa M, Kamei N, Tanaka R, Arita K, Mizuno H . Angiogenic conditioning of peripheral blood mononuclear cells promotes fracture healing. Bone Joint Res. 2017; 6(8):489-498. PMC: 5579315. DOI: 10.1302/2046-3758.68.BJR-2016-0338.R1. View